These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19697772)

  • 21. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat.
    Tanii Y; Nishikawa T; Hashimoto A; Takahashi K
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1040-8. PubMed ID: 8014848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
    Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test.
    Dambisya YM; Lee TL
    Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):179-84. PubMed ID: 8046951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia.
    Matsuoka T; Sumiyoshi T; Tanaka K; Tsunoda M; Uehara T; Itoh H; Kurachi M
    Brain Res; 2005 Aug; 1053(1-2):131-6. PubMed ID: 16051205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy.
    Qian J; Brown SD; Carlton SM
    Brain Res; 1996 Apr; 715(1-2):51-62. PubMed ID: 8739622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration.
    Fredriksson A; Archer T; Alm H; Gordh T; Eriksson P
    Behav Brain Res; 2004 Aug; 153(2):367-76. PubMed ID: 15265631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test.
    Berrino L; Oliva P; Massimo F; Aurilio C; Maione S; Grella A; Rossi F
    Eur J Pain; 2003; 7(2):131-7. PubMed ID: 12600794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.
    Winkelheide U; Lasarzik I; Kaeppel B; Winkler J; Werner C; Kochs E; Engelhard K
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):528-33. PubMed ID: 19317867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].
    Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L
    Therapie; 2001; 56(5):617-22. PubMed ID: 11806303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of Shenfu injection on hypoxic-ischemic brain damage: experiment with neonatal rats].
    Wang J; Yang LJ; Zhou CM; Zhu HM; Zhang SM
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2994-7. PubMed ID: 17288814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Making of the animal model with sterilized testes].
    Liu FH; Yang DZ; Wang YF; Liang XP; Peng WM; Cao CA; Chen XG; Guo ZM
    Zhonghua Nan Ke Xue; 2007 Feb; 13(2):125-9. PubMed ID: 17345767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sepsis on behavioral changes on the ketamine-induced animal model of schizophrenia.
    Comim CM; Silva NC; Patrício JJ; Palmas D; Mendonça BP; Bittencourt MO; Cassol OJ; Barichello T; Zugno AI; Quevedo J; Dal-Pizzol F
    J Neuroimmunol; 2015 Apr; 281():78-82. PubMed ID: 25867472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single intraperitoneal injection of ketamine does not affect spatial working, reference memory or neurodegeneration in adult mice: An animal study.
    Ribeiro PO; Rodrigues PC; Valentim AM; Antunes LM
    Eur J Anaesthesiol; 2013 Oct; 30(10):618-26. PubMed ID: 23736087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine effects on eye movements.
    Weiler MA; Thaker GK; Lahti AC; Tamminga CA
    Neuropsychopharmacology; 2000 Dec; 23(6):645-53. PubMed ID: 11063920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketamine effects on the urogenital system--changes in the urinary bladder and sperm motility.
    Tan S; Chan WM; Wai MS; Hui LK; Hui VW; James AE; Yeung LY; Yew DT
    Microsc Res Tech; 2011 Dec; 74(12):1192-8. PubMed ID: 21563274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week.
    Maia-de-Oliveira JP; Lobão-Soares B; Ramalho T; Gavioli EC; Soares VP; Teixeira L; Baker GB; Dursun SM; Hallak JE
    Schizophr Res; 2015 Mar; 162(1-3):211-5. PubMed ID: 25586741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The correlation between ketamine-induced schizophrenia-like signs in mice and the expressions of NRG1, ErbB4 mRNA].
    Bian SZ; Liu WL; Zhang ZX; Gu ZL; Jiang XG; Guo CY
    Fa Yi Xue Za Zhi; 2009 Oct; 25(5):348-51, 358. PubMed ID: 20000043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol aggravates ketamine-induced behavioral, morphological and neurochemical alterations in adolescent rats: The involvement of CREB-related pathways.
    Zuo D; Liu Y; Liu Z; Cui J; Zhou X; Liu Y; Li Z; Wu Y
    Behav Brain Res; 2018 Sep; 349():80-90. PubMed ID: 29738804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.